{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:21:43Z","timestamp":1790490103727,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1124\/jpet.118.250357","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T14:55:39Z","timestamp":1532357739000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["MALDI Mass Spectrometry Imaging Reveals Heterogeneous Distribution of Tenofovir and Tenofovir Diphosphate in Colorectal Tissue of Subjects Receiving a Tenofovir-Containing Enema"],"prefix":"10.1016","volume":"367","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-7060","authenticated-orcid":false,"given":"Herana Kamal","family":"Seneviratne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-8665","authenticated-orcid":false,"given":"Craig W.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-3824","authenticated-orcid":false,"given":"Namandj\u00e9 N.","family":"Bumpus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.250357_bib1","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1124\/jpet.118.250357_bib2","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1021\/bi301519p","article-title":"Matrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping","volume":"52","author":"Angel","year":"2013","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.118.250357_bib3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1089\/aid.2012.0262","article-title":"RMP-02\/MTN-006: a phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate","volume":"28","author":"Anton","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1124\/jpet.118.250357_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-med-050911-163701","article-title":"Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis","volume":"64","author":"Baeten","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1124\/jpet.118.250357_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2174\/1570162X12666140129100411","article-title":"PrEP awareness and perceived barriers among single young men who have sex with men","volume":"11","author":"Bauermeister","year":"2013","journal-title":"Curr HIV Res"},{"key":"10.1124\/jpet.118.250357_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/jpet.105.084301","article-title":"Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6)","volume":"314","author":"Bleasby","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.250357_bib7","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1007\/s00216-018-0964-3","article-title":"MALDI imaging facilitates new topical drug development process by determining quantitative skin distribution profiles","volume":"410","author":"Bonnel","year":"2018","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/jpet.118.250357_bib8","doi-asserted-by":"crossref","first-page":"e0181607","DOI":"10.1371\/journal.pone.0181607","article-title":"High levels of adherence to a rectal microbicide gel and to oral pre-exposure prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women","volume":"12","author":"Carballo-Di\u00e9guez","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/jpet.118.250357_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bcp.2006.09.014","article-title":"Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge","volume":"73","author":"De Clercq","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.118.250357_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1521\/aeap.2015.27.4.289","article-title":"Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan","volume":"27","author":"Dolezal","year":"2015","journal-title":"AIDS Educ Prev"},{"key":"10.1124\/jpet.118.250357_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/apc.2014.0303","article-title":"Minimal awareness and stalled uptake of pre-exposure prophylaxis (PrEP) among at risk, HIV-negative, black men who have sex with men","volume":"29","author":"Eaton","year":"2015","journal-title":"AIDS Patient Care STDS"},{"key":"10.1124\/jpet.118.250357_bib12","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s10461-016-1565-9","article-title":"Preferences for long-acting pre-exposure prophylaxis (PrEP), daily oral PrEP, or condoms for HIV prevention among U.S. men who have sex with men","volume":"21","author":"Greene","year":"2017","journal-title":"AIDS Behav"},{"key":"10.1124\/jpet.118.250357_bib13","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.jprot.2011.03.032","article-title":"Mass spectrometry imaging for drugs and metabolites","volume":"74","author":"Greer","year":"2011","journal-title":"J Proteomics"},{"key":"10.1124\/jpet.118.250357_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.qai.0000167155.44980.e8","article-title":"Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens","volume":"39","author":"Hawkins","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1124\/jpet.118.250357_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/aid.2015.0182","article-title":"Dose frequency ranging pharmacokinetic study of tenofovir-emtricitabine after directly observed dosing in healthy volunteers to establish adherence benchmarks (HPTN 066)","volume":"32","author":"Hendrix","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1124\/jpet.118.250357_bib16","doi-asserted-by":"crossref","first-page":"e55013","DOI":"10.1371\/journal.pone.0055013","article-title":"MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments","volume":"8","author":"Hendrix","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.118.250357_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.106.028233","article-title":"Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir","volume":"71","author":"Imaoka","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.118.250357_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/00003088-200443090-00003","article-title":"Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics","volume":"43","author":"Kearney","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.118.250357_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e31815e7478","article-title":"Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients","volume":"47","author":"Kiser","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1124\/jpet.118.250357_bib20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ebiom.2015.07.008","article-title":"Discovery of genetic variants of the kinases that activate tenofovir in a compartment-specific manner","volume":"2","author":"Lade","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1124\/jpet.118.250357_bib21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1089\/aid.2013.0044","article-title":"Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue","volume":"29","author":"Louissaint","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1124\/jpet.118.250357_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/00498250500354493","article-title":"Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites","volume":"35","author":"Mallants","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.118.250357_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.it.2013.10.003","article-title":"Dendritic cells in progression and pathology of HIV infection","volume":"35","author":"Manches","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1124\/jpet.118.250357_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7326\/0003-4819-111-3-223","article-title":"CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection","volume":"111","author":"Masur","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.118.250357_bib25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1081\/NCN-100002483","article-title":"Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples","volume":"20","author":"Miller","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1124\/jpet.118.250357_bib26","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/09540121.2016.1168911","article-title":"HIV-negative male couples\u2019 attitudes about pre-exposure prophylaxis (PrEP) and using PrEP with a sexual agreement","volume":"28","author":"Mitchell","year":"2016","journal-title":"AIDS Care"},{"key":"10.1124\/jpet.118.250357_bib27","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/AAC.42.7.1568","article-title":"Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice","volume":"42","author":"Naesens","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.118.250357_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1124\/jpet.118.250357_bib29","doi-asserted-by":"crossref","first-page":"112re4","DOI":"10.1126\/scitranslmed.3003174","article-title":"Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission","volume":"3","author":"Patterson","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1124\/jpet.118.250357_bib30","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/AAC.00251-06","article-title":"Mechanism of active renal tubular efflux of tenofovir","volume":"50","author":"Ray","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.118.250357_bib31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.42.3.612","article-title":"Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA","volume":"42","author":"Robbins","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.118.250357_bib32","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.02793-15","article-title":"Differential mechanisms of tenofovir and tenofovir disoproxil fumarate cellular transport and implications for topical preexposure prophylaxis","volume":"60","author":"Taneva","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.118.250357_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10822-005-8694-y","article-title":"Virtual computational chemistry laboratory--design and description","volume":"19","author":"Tetko","year":"2005","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/jpet.118.250357_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"van Meer","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/jpet.118.250357_bib35","doi-asserted-by":"crossref","first-page":"e106196","DOI":"10.1371\/journal.pone.0106196","article-title":"A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.250357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:01:29Z","timestamp":1739995289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524267008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0022356524267008"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.250357","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MALDI Mass Spectrometry Imaging Reveals Heterogeneous Distribution of Tenofovir and Tenofovir Diphosphate in Colorectal Tissue of Subjects Receiving a Tenofovir-Containing Enema","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.250357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}